The One Health Initiative was established to promote the consolidation of approaches to global health, including human, animal, and environmental health.

Multifactorial diseases such as non-alcoholic fatty liver disease (NAFLD), inflammatory bowel diseases, or Parkinson’s disease have been challenging to investigate and are poorly replicated for experimental purposes using traditional scientific approaches.

One Medicine describes an approach where veterinary and human medicine are approached as a branch of the same large medicine to share knowledge.

The One Health Initiative promotes a tool for connecting the knowledge between the medical branches called reverse translational research. Data and information from human and veterinary clinical research can be under the right conditions translated between the biomedical fields and this kind of research can further benefit both human and veterinary patients.